Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beam Therapeutics (BEAM) Profit After Tax (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Profit After Tax for 7 consecutive years, with -$78.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 12.91% to -$78.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$80.0 million, a 78.77% increase, with the full-year FY2025 number at -$80.0 million, up 78.77% from a year prior.
  • Profit After Tax was -$78.7 million for Q4 2025 at Beam Therapeutics, down from -$200000.0 in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $142.8 million in Q4 2023 to a low of -$201.6 million in Q1 2021.
  • A 5-year average of -$62.4 million and a median of -$77.5 million in 2021 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: crashed 561.76% in 2021, then skyrocketed 472.36% in 2023.
  • Beam Therapeutics' Profit After Tax stood at -$64.7 million in 2021, then soared by 40.73% to -$38.3 million in 2022, then surged by 472.36% to $142.8 million in 2023, then crashed by 163.27% to -$90.4 million in 2024, then increased by 12.91% to -$78.7 million in 2025.
  • Per Business Quant, the three most recent readings for BEAM's Profit After Tax are -$78.7 million (Q4 2025), -$200000.0 (Q3 2025), and -$200000.0 (Q2 2025).